We are live on ! Find out more
ELAN icon

Elanco Animal Health

400 hedge funds and large institutions have $10.9B invested in Elanco Animal Health in 2019 Q4 according to their latest regulatory filings, with 86 funds opening new positions, 139 increasing their positions, 116 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 56

20% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 116

10% more capital invested

Capital invested by funds: $9.85B → $10.9B (+$1.03B)

6% more funds holding

Funds holding: 376400 (+24)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0.57% less ownership

Funds ownership: 99.62%99.06% (-0.57%)

8% less call options, than puts

Call options by funds: $35M | Put options by funds: $38.1M

Holders
400
Holders Change
+24
Holders Change %
+6.38%
% of All Funds
7.88%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
86
Increased
139
Reduced
116
Closed
56
Calls
$35M
Puts
$38.1M
Net Calls
-$3.07M
Net Calls Change
+$21.6M
Name Holding Trade Value Shares
Change
Change in
Stake
DTL
276
Dynamic Technology Lab
Singapore
$359K +$59.7K +2,197 +22%
SMC
277
S. Muoio & Co
New York
$327K +$302K +11,100 New
AI
278
Atria Investments
North Carolina
$327K +$302K +11,109 New
Qube Research & Technologies (QRT)
279
Qube Research & Technologies (QRT)
United Kingdom
$326K +$300K +11,053 New
Brown Advisory
280
Brown Advisory
Maryland
$324K -$2.77K -102 -0.9%
TSS
281
Two Sigma Securities
New York
$314K +$290K +10,666 New
LTFS
282
Ladenburg Thalmann Financial Services
Florida
$311K -$51.7K -1,902 -15%
FAAS
283
First Allied Advisory Services
California
$309K +$40.8K +1,502 +17%
FHB
284
First Hawaiian Bank
Hawaii
$300K +$47.1K +1,732 +20%
FMWA
285
Forvis Mazars Wealth Advisors
Missouri
$298K -$38.7K -1,425 -12%
LFAS
286
Level Four Advisory Services
Texas
$285K +$20.4K +750 +8%
OAM
287
Oppenheimer Asset Management
New York
$283K -$17.9K -658 -6%
PAS
288
Park Avenue Securities
New York
$281K +$259K +9,529 New
HCM
289
Hodges Capital Management
Texas
$280K +$258K +9,500 New
M&T Bank
290
M&T Bank
New York
$277K +$245 +9 +0.1%
Manulife (Manufacturers Life Insurance)
291
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$275K -$9.76K -359 -4%
QI
292
QS Investors
New York
$275K
PG
293
Pendal Group
Australia
$272K -$2.04K -75 -0.8%
NSEDCP
294
NJ State Employees Deferred Compensation Plan
New Jersey
$271K
Mackenzie Financial
295
Mackenzie Financial
Ontario, Canada
$271K +$250K +9,187 New
MLICM
296
Metropolitan Life Insurance Company (MetLife)
New York
$267K +$815 +30 +0.3%
FC
297
FORA Capital
Florida
$264K +$244K +8,975 New
ProShare Advisors
298
ProShare Advisors
Maryland
$263K +$3.83K +141 +2%
Rockefeller Capital Management
299
Rockefeller Capital Management
New York
$249K +$13.2K +486 +6%
SSWM
300
Smith Salley Wealth Management
North Carolina
$228K +$210K +7,735 New

ELAN Hedge Fund Activity: Q4 2019 in Review

400 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2019, worth a combined $10.9B — up 10% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new ELAN positions and 56 closed out — a net gain of 30 holders — while 139 added to existing stakes and 116 trimmed.

The largest buyer was Amundi Asset Management US, adding an estimated $146M. The largest seller was Morgan Stanley, cutting an estimated $230M.

  • 400 institutional investors held Elanco Animal Health (ELAN) as of Q4 2019, up from 376 in Q3 2019.
  • Funds reported $10.9B of Elanco Animal Health stock for Q4 2019, up 10% quarter-over-quarter.
  • 86 funds opened new Elanco Animal Health positions in Q4 2019 and 56 closed out, a net change of +30 holders.
  • The largest Elanco Animal Health buyer in Q4 2019 was Amundi Asset Management US, an estimated $146M added.
  • The largest Elanco Animal Health seller in Q4 2019 was Morgan Stanley, an estimated $230M sold.

Based on aggregated 13F filings for Q4 2019.